weight loss semaglutide covington EZCare Moorefield Walk- In Medical Center is now offering and Tirzepatide for loss! Weight Loss with Semaglutide -

For patients managing prediabetes or borderline hypertension, these secondary benefits are often just as motivating as the number on the scale

But because the landscape around compounded GLP-1 medications has shifted dramatically since the FDA resolved the semaglutide shortage in February 2025, and what was once a straightforward decision now involves regulatory gray areas, legal battles, and quality control questions that most people never expected to navigate

Novo responded the same day, publicly characterizing the product as "illegal mass compounding that poses a significant risk to patient safety." On February 6, the FDA announced it would take action against companies mass-marketing unapproved compounded GLP-1 products, and HHS General Counsel stated publicly that the department had referred Hims to the DOJ for potential FDCA violations

Unexpected rapid weight loss (more than 23 pounds per week consistently) warrants a check-in with your care provider, as it may suggest underlying illness, excessive calorie restriction, or individual hypersensitivity

Integration of Retatrutide into Clinical and Research Settings Retatrutide is primarily discussed in the context of metabolic research and specialized clinical programs